Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy

Summary

Phase II trial of AZD2014 in RICTOR amplified or overexpressed GC patients as second-line chemotherapy AZD2014 50mg BD continuous schedule of a 28 day cycle

Timeline

Start

2017-02-01

Primary completion

2018-11-16

Completion

2018-11-16

Outcome

Outcome not reported

Stopped: “lack of efficacy”

Drugs

Indications